Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls

By Microbix Admin | November 2, 2022

https://microbix.com/wp-content/QAP/Poster%20Publications/SARS/ECCMID2021_SARS%20Ab.pdf